Role of tamsulosin, solifenacin, and combination therapy in the management of Double J stent related symptoms
Keywords:
We believe that pharmacologic management is simpler and less invasive than other waysAbstract
Ureteral stents, which were introduced by Zimskind et al in 1967, are widely used for urinary tract disease.1 The double-J stent, which is the most common form of ureteral stent, is used in obstructive pyelonephritis, intolerable acute renal colic, ureteral edema, ureter perforation following endoscopic procedures, and diseases such as stein- strasse.2,3 Despite the usefulness of stents, however, patients experience various stent-related symptoms, such as pain, frequency and urgency, which cause a significant decrease in patient health-related quality of life (HRQoL).4.
Downloads
Published
2022-04-30
Issue
Section
Articles